MeSH term
Frequency | Condition_Probility | Animals | 31 | 0.0 |
COS Cells | 8 | 0.0 |
Carrier Proteins/*metabolism | 14 | 1.0 |
Cell Line | 23 | 0.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
Humans | 60 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 50 | 7.0 |
Mice | 19 | 0.0 |
Nuclear Proteins/*metabolism | 7 | 1.0 |
Research Support, Non-U.S. Gov't | 51 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 29 | 0.0 |
Transcription, Genetic | 9 | 0.0 |
Viral Proteins/genetics/*metabolism | 2 | 3.0 |
Binding Sites | 5 | 0.0 |
Carrier Proteins/genetics/*metabolism | 8 | 1.0 |
Cell Nucleus/metabolism | 15 | 0.0 |
Fluorescent Antibody Technique | 3 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 7 | 2.0 |
Precipitin Tests | 8 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Protein Structure, Tertiary | 7 | 0.0 |
Two-Hybrid System Techniques | 9 | 0.0 |
Repressor Proteins/*physiology | 2 | 1.0 |
*Antigens, Nuclear | 2 | 1.0 |
Blotting, Western | 5 | 0.0 |
Female | 5 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Apoptosis/physiology | 3 | 0.0 |
Down-Regulation | 3 | 0.0 |
Intracellular Signaling Peptides and Proteins/*metabolism | 2 | 40.0 |
Protein p53/*metabolism | 2 | 0.0 |
Base Sequence | 7 | 0.0 |
DNA Primers | 2 | 0.0 |
*Nuclear Proteins | 15 | 0.0 |
*Trans-Activation (Genetics) | 3 | 0.0 |
*Apoptosis | 8 | 0.0 |
Cell Division | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Jurkat Cells | 3 | 0.0 |
Kinetics | 2 | 0.0 |
Plasmids/metabolism | 4 | 0.0 |
Protein Binding | 14 | 0.0 |
Protein Transport | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Time Factors | 4 | 0.0 |
*Transcription, Genetic | 6 | 0.0 |
*Arabidopsis Proteins | 4 | 4.0 |
Genes, Dominant | 2 | 0.0 |
Genes, Reporter | 3 | 0.0 |
MAP Kinase Kinase Kinase 5 | 4 | 17.0 |
MAP Kinase Kinase Kinases/*metabolism | 3 | 8.0 |
Microscopy, Fluorescence | 6 | 0.0 |
Signal Transduction | 8 | 0.0 |
Transfection | 12 | 0.0 |
Antigens, CD95/metabolism | 4 | 2.0 |
Carrier Proteins/metabolism | 3 | 0.0 |
Caspases/*metabolism | 3 | 1.0 |
Gene Deletion | 4 | 0.0 |
Mutation | 3 | 0.0 |
Mitogen-Activated Protein Kinase 8 | 2 | 2.0 |
Signal Transduction/genetics | 2 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Cells, Cultured | 7 | 0.0 |
Mice, Knockout | 5 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Male | 10 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Cell Nucleus Structures/*metabolism | 2 | 25.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Hela Cells | 12 | 0.0 |
Luminescent Proteins/genetics/metabolism | 2 | 1.0 |
Molecular Sequence Data | 11 | 0.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Nuclear Proteins/metabolism | 7 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
Antigens, CD95/*metabolism | 3 | 2.0 |
Apoptosis/*physiology | 5 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Japan | 2 | 0.0 |
Linkage (Genetics)/genetics | 2 | 0.0 |
Major Histocompatibility Complex/*genetics | 2 | 1.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Plant Proteins/metabolism | 2 | 10.0 |
DNA, Complementary | 2 | 0.0 |
*Major Histocompatibility Complex | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 10 | 1.0 |
Mitogen-Activated Protein Kinases/*metabolism | 4 | 0.0 |
Proteins/genetics/*physiology | 2 | 1.0 |
Cercopithecus aethiops | 3 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Arsenicals/pharmacology | 3 | 14.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 3 | 0.0 |
Neoplasm Proteins/*metabolism | 3 | 0.0 |
Oxides/pharmacology | 3 | 21.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Carrier Proteins/metabolism/*physiology | 2 | 5.0 |
Caspases/metabolism | 4 | 0.0 |
Down-Regulation/drug effects | 2 | 0.0 |
Hydroxamic Acids/pharmacology | 2 | 1.0 |
Proteins/metabolism | 4 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 2 | 0.0 |
Up-Regulation/drug effects | 2 | 0.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
Enzyme Activation | 8 | 0.0 |
*Mitogen-Activated Protein Kinases | 4 | 1.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Cell Line, Tumor | 8 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 3 | 0.0 |
Antigens, CD95/*physiology | 2 | 2.0 |
Doxorubicin/pharmacology | 2 | 0.0 |
Ultraviolet Rays | 3 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Immunoblotting | 4 | 0.0 |
Models, Biological | 3 | 0.0 |
Phosphorylation | 5 | 0.0 |
Prostatic Neoplasms/metabolism | 2 | 3.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Apoptosis | 2 | 0.0 |
DNA/chemistry | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Mutagenesis/physiology | 2 | 2.0 |
Signal Transduction/physiology | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
RNA Interference | 2 | 0.0 |
Carrier Proteins/chemistry/*physiology | 2 | 5.0 |
Gene Expression Regulation | 2 | 0.0 |
Nuclear Proteins/chemistry/*physiology | 2 | 10.0 |
Drug Synergism | 2 | 0.0 |
TNF Receptor-Associated Factor 2 | 2 | 0.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
RNA, Small Interfering/metabolism | 2 | 1.0 |
Chromatin/*metabolism | 2 | 1.0 |
Carrier Proteins/genetics/metabolism | 2 | 1.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
Up-Regulation/genetics | 2 | 2.0 |
